What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cancer
T cell, Molecular biology, Cell biology, Antigen and Immunology are his primary areas of study.
He has researched T cell in several fields, including Cytotoxic T cell, Signal transduction, Monoclonal antibody and Dipeptidyl peptidase.
His Molecular biology research includes elements of Intermediate filament, Calponin homology domain, Integrin, Cell adhesion and Epitope.
His Cell biology study integrates concerns from other disciplines, such as Internal medicine, IL-2 receptor, Endocrinology and CD40.
His Antigen research is multidisciplinary, relying on both Receptor, Biochemistry, Jurkat cells and Transfection.
His Antigen-presenting cell research integrates issues from CD28 and Interleukin 21.
His most cited work include:
- The isolation and characterization of the human suppressor inducer T cell subset. (751 citations)
- The isolation and characterization of the human helper inducer T cell subset. (618 citations)
- Direct association of adenosine deaminase with a T cell activation antigen, CD26 (439 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Molecular biology, T cell, Immunology, Cell biology and Antigen.
His Molecular biology research focuses on Monoclonal antibody and how it relates to Cancer research and Mesothelioma.
His T cell research includes themes of Cytotoxic T cell, Biochemistry and Dipeptidyl peptidase.
Chikao Morimoto has included themes like Cell, In vitro and Inducer in his Immunology study.
His Cell biology study combines topics from a wide range of disciplines, such as Receptor and Integrin.
His research integrates issues of Suppressor and Immune system in his study of Antigen.
He most often published in these fields:
- Molecular biology (40.00%)
- T cell (35.70%)
- Immunology (31.39%)
What were the highlights of his more recent work (between 2012-2021)?
- Cancer research (20.76%)
- Monoclonal antibody (17.47%)
- Immunology (31.39%)
In recent papers he was focusing on the following fields of study:
Chikao Morimoto mostly deals with Cancer research, Monoclonal antibody, Immunology, Antibody and Molecular biology.
Chikao Morimoto combines subjects such as Cell, Apoptosis, Antigen, Signal transduction and CD38 with his study of Cancer research.
His study in Immunology is interdisciplinary in nature, drawing from both In vitro, Graft-versus-host disease and Enzyme.
His Antibody research incorporates themes from Immunostaining, Immune system and Dipeptidyl peptidase.
His work deals with themes such as Nucleus, Gene expression, Gene and Dipeptidyl peptidase-4, which intersect with Molecular biology.
He focuses mostly in the field of Cytokine, narrowing it down to topics relating to T cell and, in certain cases, Endocrinology.
Between 2012 and 2021, his most popular works were:
- Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody (68 citations)
- Identification of senescent cell surface targetable protein DPP4. (67 citations)
- CD26-mediated co-stimulation in human CD8(+) T cells provokes effector function via pro-inflammatory cytokine production. (51 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
His main research concerns Cancer research, Immunology, Cell, Antibody and Monoclonal antibody.
His work carried out in the field of Cancer research brings together such families of science as In vitro, Inflammation, Cancer cell, Antigen and Signal transduction.
Chikao Morimoto interconnects Parenchyma, Graft-versus-host disease and Enzyme in the investigation of issues within Immunology.
The various areas that Chikao Morimoto examines in his Cell study include Molecular biology, Transcription factor, Cell growth and Proto-oncogene tyrosine-protein kinase Src.
His study looks at the relationship between Antibody and topics such as Dipeptidyl peptidase-4, which overlap with Pharmacology, Immune regulation and Hormone.
His T cell study which covers NFATC Transcription Factors that intersects with Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
